In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
14 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
10 March 2020 Pre-consultation documents released
26 March 2019 Declaration of interests
24 October 2018 Committee list updated
03 October 2018 Scope published
03 October 2018 Scope published
03 October 2018 Committee meeting
16 May 2018 - 13 June 2018 Draft scope consultation
14 May 2018 - 13 June 2018 Committee member recruitment
02 May 2018 Stakeholder list updated
12 April 2018 Scoping workshop
02 February 2018 - 13 February 2018 Committee chair recruitment
03 January 2018 - 17 January 2018 Committee chair recruitment

For further information on the guideline development process, please read how we develop NICE guidelines